Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report

BACKGROUND: Craniopharyngiomas account for approximately 1.2–4% of all CNS tumors. They are typically treated with a combination of surgical resection and focal radiotherapy. Unfortunately, treatment can lead to permanent deleterious effects on behavior, learning, and endocrine function. METHODS: Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Goldman, Stewart, Pollack, Ian F, Jakacki, Regina I, Billups, Catherine A, Poussaint, Tina Y, Adesina, Adekunle M, Panigrahy, Ashok, Parsons, Donald W, Broniscer, Alberto, Robinson, Giles W, Robison, Nathan J, Partap, Sonia, Kilburn, Lindsay B, Onar-Thomas, Arzu, Dunkel, Ira J, Fouladi, Maryam
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Pediatric Neuro-Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690365/
https://ncbi.nlm.nih.gov/pubmed/32393959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados